Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib

被引：1
|
作者：
Wang, Hanyin
Tian, Shulan
Zhao, Qing
Blumenschein, Wendy
Yearley, Jennifer H.
Secreto, Charla R.
Sinha, Sutapa
Call, Timothy G.
Wang, Yucai
Parikh, Sameer A.
Kenderian, Saad S.
He, Rong
Leis, Jose F.
Shi, Min
Kay, Neil E.
Slager, Susan L.
Braggio, Esteban
Yan, Huihuang
Ding, Wei
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Chronic lymphocytic leukemia in (Richter's) transformation
    Giles, FJ
    O'Brien, SM
    Keating, MJ
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 117 - 125
  • [22] Richter's Transformation of Chronic Lymphocytic Leukemia
    Giardino, Angela A.
    O'Regan, Kevin
    Jagannathan, Jyothipriya P.
    Elco, Chrisopher
    Ramaiya, Nikhil
    Lacasce, Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : E274 - E276
  • [23] Richter's transformation in chronic lymphocytic leukemia
    Tsimberidou, AM
    Keating, MJ
    SEMINARS IN ONCOLOGY, 2006, 33 (02) : 250 - 256
  • [24] Near-Tetraploidy Is Strongly Associated with Development of Richter's Transformation in Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib
    Miller, Cecelia R.
    Ruppert, Amy S.
    Heerema, Nyla A.
    Maddocks, Kami J.
    Labanowska, Jadwiga
    Breidenbach, Heather
    Lozanski, Gerard
    Zhao, Weiqiang
    Gordon, Amber
    Jones, Jeffrey
    Flynn, Joseph M.
    Jaglowski, Samantha
    Andritsos, Leslie A.
    Awan, Farrukh T.
    Blum, Kristie A.
    Grever, Michael R.
    Johnson, Amy J.
    Abruzzo, Lynne V.
    Hertlein, Erin K.
    Woyach, Jennifer A.
    Byrd, John C.
    BLOOD, 2016, 128 (22)
  • [25] EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia
    Hussaini, Mohammad O.
    Rehman, Alman
    Chavez, Julio C.
    Pinilla-Ibarz, Javier
    Horna, Pedro
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1753 - 1756
  • [26] Ibrutinib in Treatment of Patients with chronic lymphocytic Leukemia
    Flammiger, A.
    ONKOLOGE, 2015, 21 (08): : 732 - 733
  • [27] Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia
    Parikh, Sameer A.
    Shanafelt, Tait D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (03) : 294 - 299
  • [28] Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax
    Gango, Ambrus
    Kiss, Richard
    Farkas, Peter
    Hanna, Eid
    Demeter, Judit
    Deak, Beata
    Levai, Dora
    Kotmayer, Lili
    Alpar, Donat
    Matolcsy, Andras
    Bodor, Csaba
    Matrai, Zoltan
    Timar, Botond
    PATHOLOGY, 2022, 54 (01) : 95 - 103
  • [29] Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia
    Sameer A. Parikh
    Tait D. Shanafelt
    Current Hematologic Malignancy Reports, 2014, 9 : 294 - 299
  • [30] Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia
    Innocenti, Idanna
    Rossi, Davide
    Trape, Giulio
    Autore, Francesco
    Larocca, Luigi Maria
    Gomes, Vincenzo
    Cerri, Michaela
    Falcucci, Paolo
    Sica, Simona
    Gaidano, Gianluca
    Laurenti, Luca
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 600 - 603
12345